beta-Nicotinamide mononucleotide, reduced form (NMNH) disodium is an orally active reduced version of beta-Nicotinamide mononucleotide (HY-F0004). beta-Nicotinamide mononucleotide, reduced form disodium can significantly increase the levels of NAD+ and NADH, inhibit glycolysis, the tricarboxylic acid cycle, and cell growth, with its effects being dependent on nicotinamide mononucleotide adenylyltransferase (NMNAT)[1][2].
Molekulargewicht:
380.20
Reinheit:
99.55
CAS Nummer:
[108347-85-9]
Formel:
C11H15N2Na2O8P
Target-Kategorie:
Endogenous Metabolite
Anwendungsbeschreibung:
MCE Product type: Biochemical Assay Reagents
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten